Skip to main content

Table 3 The cost-utility analysis of different screening strategy

From: Quality assurance target for community-based breast cancer screening in China: a model simulation

Screening Strategy Utility
(QALY)
Cost
(million USD)
ICURa
(USD/QALY)
ICURb
(USD/QALY)
CU
(USD/QALY)
No screen 2388 195 96.08 40.23
1/3 years 2388 782 100.23 7075.77 7075.77 41.96
1/2 years 2389 034 102.28 7394.60 8137.29 42.81
1/1 year 2389 778 108.27 7701.68 8047.96 45.30
  1. Abbreviations: CU Cost/Utility, ICUR incremental cost-utility ratio, QALY quality-adjusted life-year
  2. ICUR a based on the no screen strategy; ICUR b based on the previous screening strategy